These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 19492231)

  • 1. XPD polymorphisms, cigarette smoking, and bladder cancer risk: a meta-analysis.
    Wang M; Gu D; Zhang Z; Zhou J; Zhang Z
    J Toxicol Environ Health A; 2009; 72(11-12):698-705. PubMed ID: 19492231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Xeroderma pigmentosum group D polymorphisms and esophageal cancer susceptibility: a meta-analysis based on case-control studies.
    Yang R; Zhang C; Malik A; Shen ZD; Hu J; Wu YH
    World J Gastroenterol; 2014 Nov; 20(44):16765-73. PubMed ID: 25469049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymorphisms in XPD exons 10 and 23 and bladder cancer risk.
    Schabath MB; Delclos GL; Grossman HB; Wang Y; Lerner SP; Chamberlain RM; Spitz MR; Wu X
    Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):878-84. PubMed ID: 15824159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Association of genetic polymorphisms in the DNA repair gene XPD with risk of lung and esophageal cancer in a Chinese population in Beijing].
    Xing DY; Qi J; Tan W; Miao XP; Liang G; Yu CY; Lu WF; Zhou CN; Wu M; Lin DX
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Feb; 20(1):35-8. PubMed ID: 12579497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of XPD and APE1 DNA repair gene polymorphism on bladder cancer susceptibility in north India.
    Gangwar R; Ahirwar D; Mandhani A; Mittal RD
    Urology; 2009 Mar; 73(3):675-80. PubMed ID: 19041121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphisms of the DNA repair genes XRCC1, XRCC3, XPD, interaction with environmental exposures, and bladder cancer risk in a case-control study in northern Italy.
    Shen M; Hung RJ; Brennan P; Malaveille C; Donato F; Placidi D; Carta A; Hautefeuille A; Boffetta P; Porru S
    Cancer Epidemiol Biomarkers Prev; 2003 Nov; 12(11 Pt 1):1234-40. PubMed ID: 14652287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. XPA A23G, XPC Lys939Gln, XPD Lys751Gln and XPD Asp312Asn polymorphisms, interactions with smoking, alcohol and dietary factors, and risk of colorectal cancer.
    Hansen RD; Sørensen M; Tjønneland A; Overvad K; Wallin H; Raaschou-Nielsen O; Vogel U
    Mutat Res; 2007 Jun; 619(1-2):68-80. PubMed ID: 17363013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Xeroderma pigmentosum complementation group D (XPD) gene polymorphisms contribute to bladder cancer risk: a meta-analysis.
    Li SX; Dai QS; Chen SX; Zhang SD; Liao XY; Deng X; Chi HB; Li FJ; Zhu JH; Jiang YY
    Tumour Biol; 2014 Apr; 35(4):3905-15. PubMed ID: 24347488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. XPD codon 751 polymorphism, metabolism genes, smoking, and bladder cancer risk.
    Stern MC; Johnson LR; Bell DA; Taylor JA
    Cancer Epidemiol Biomarkers Prev; 2002 Oct; 11(10 Pt 1):1004-11. PubMed ID: 12376500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of the DNA repair gene XPD Asp312Asn polymorphism with p53 gene mutations in tobacco-related non-small cell lung cancer.
    Gao WM; Romkes M; Day RD; Siegfried JM; Luketich JD; Mady HH; Melhem MF; Keohavong P
    Carcinogenesis; 2003 Oct; 24(10):1671-6. PubMed ID: 12844488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. XPD Lys751Gln and Asp312Asn polymorphisms and gastric cancer susceptibility: a meta-analysis of case-control studies.
    Yin QH; Liu C; Hu JB; Meng RR; Li L; Wang YJ
    Asian Pac J Cancer Prev; 2013; 14(1):231-6. PubMed ID: 23534729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymorphisms in base-excision repair and nucleotide-excision repair genes in relation to lung cancer risk.
    De Ruyck K; Szaumkessel M; De Rudder I; Dehoorne A; Vral A; Claes K; Velghe A; Van Meerbeeck J; Thierens H
    Mutat Res; 2007 Jul; 631(2):101-10. PubMed ID: 17531525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphisms in XPD (Asp312Asn and Lys751Gln) genes, sunburn and arsenic-related skin lesions.
    McCarty KM; Smith TJ; Zhou W; Gonzalez E; Quamruzzaman Q; Rahman M; Mahiuddin G; Ryan L; Su L; Christiani DC
    Carcinogenesis; 2007 Aug; 28(8):1697-702. PubMed ID: 17470448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between XPD Lys751Gln polymorphism and risk of head and neck cancer: a meta-analysis.
    Yuan H; Niu YM; Wang RX; Li HZ; Chen N
    Genet Mol Res; 2011 Nov; 10(4):3356-64. PubMed ID: 22179996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene-environment interaction for the ERCC2 polymorphisms and cumulative cigarette smoking exposure in lung cancer.
    Zhou W; Liu G; Miller DP; Thurston SW; Xu LL; Wain JC; Lynch TJ; Su L; Christiani DC
    Cancer Res; 2002 Mar; 62(5):1377-81. PubMed ID: 11888908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphism of DNA repair genes OGG1, XRCC1, XPD and ERCC6 in bladder cancer in Belarus.
    Ramaniuk VP; Nikitchenko NV; Savina NV; Kuzhir TD; Rolevich AI; Krasny SA; Sushinsky VE; Goncharova RI
    Biomarkers; 2014 Sep; 19(6):509-16. PubMed ID: 25089939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of association between XPD Lys751Gln and Asp312Asn polymorphisms and colorectal cancer risk: a meta-analysis of case-control studies.
    Zhang Y; Ding D; Wang X; Zhu Z; Huang M; He X
    Int J Colorectal Dis; 2011 Oct; 26(10):1257-64. PubMed ID: 21541661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymorphisms in the DNA repair genes XPC, XPD, and XPG and risk of cutaneous melanoma: a case-control analysis.
    Li C; Hu Z; Liu Z; Wang LE; Strom SS; Gershenwald JE; Lee JE; Ross MI; Mansfield PF; Cormier JN; Prieto VG; Duvic M; Grimm EA; Wei Q
    Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2526-32. PubMed ID: 17164380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorphisms/haplotypes in DNA repair genes and smoking: a bladder cancer case-control study.
    Matullo G; Guarrera S; Sacerdote C; Polidoro S; Davico L; Gamberini S; Karagas M; Casetta G; Rolle L; Piazza A; Vineis P
    Cancer Epidemiol Biomarkers Prev; 2005 Nov; 14(11 Pt 1):2569-78. PubMed ID: 16284380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic polymorphisms of xeroderma pigmentosum group D and prostate cancer risk: a meta-analysis.
    Zhu H; Cao S; Liu Y; Ding X; Wu Q; Ma H
    J Cancer Res Ther; 2013; 9(2):187-92. PubMed ID: 23771356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.